SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Form
Filing Date
May 7, 2021
Document Date
May 5, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Jazz Pharmaceuticals plc
Issuer
Jazz Pharmaceuticals plc
Filer
Tovey Christopher J.